newsfilter
← Latest News
GlobeNewswire·

Synergy CHC Corp. Announces Receipt of Nasdaq Letter

SNYR
  • Synergy CHC Corp. received a notice from Nasdaq on August 20, 2026, for non-compliance with Listing Rule 5250(c)(1) due to the delayed filing of its Q2 Form 10-Q for the period ended June 30, 2026.
  • The notice does not immediately affect the listing or trading of the Company's common stock on Nasdaq.
  • The Company has until October 19, 2026, to submit a plan of compliance to Nasdaq.
  • Nasdaq may grant an extension of up to 180 calendar days from the Q2 Form 10-Q due date, extending the compliance deadline to February 10, 2027.
  • The Company currently cannot predict when or whether the Q2 Form 10-Q will be filed or if it will regain compliance with the Listing Rule.
  • Synergy CHC Corp. markets consumer health products including FOCUSfactor® 8 Flat Tummy® through major retailers in the U.S., Canada, 8 Mexico.